Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

Conditions

• Melanoma (Skin)

Interventions

• BIOLOGICAL: HLA-A1-binding MAGE-1/MAGE-3 multipeptide-pulsed autologous dendritic cell vaccine
• BIOLOGICAL: HLA-A2-binding TYR/MART-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine
• BIOLOGICAL: autologous melanoma lysate-pulsed autologous dendritic cell vaccine
• BIOLOGICAL: autologous melanoma lysate/KLH-pulsed autologous dendritic cell vaccine
• BIOLOGICAL: dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
• OTHER: flow cytometry
• PROCEDURE: adjuvant therapy

Sponsor

Maria Sklodowska-Curie National Research Institute of Oncology